ALLO - Allogene Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

ALLO is currently covered by 16 analysts with an average price target of $16.42. This is a potential upside of $12.92 (369.14%) from yesterday's end of day stock price of $3.5.

Allogene Therapeutics's activity chart (see below) currently has 93 price targets and 107 ratings on display. The stock rating distribution of ALLO is 80.95% BUY, 16.67% HOLD and 2.38% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25.8% with an average time for these price targets to be met of 80.79 days.

Highest price target for ALLO is $10, Lowest price target is $5, average price target is $16.42.

Most recent stock forecast was given by BRIAN CHENG from JPMORGAN on 27-Feb-2024. First documented stock forecast 05-Nov-2018.

Currently out of the existing stock ratings of ALLO, 34 are a BUY (80.95%), 7 are a HOLD (16.67%), 1 are a SELL (2.38%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

8

$4.02 (101.01%)

9

1 months 25 days ago

0/3 (0%)

$2.86 (55.64%)

Buy

10

$6.02 (151.26%)

12

3 months 2 days ago

1/7 (14.29%)

$6.91 (223.62%)

28

Buy

10

$6.02 (151.26%)

12

3 months 2 days ago

0/5 (0%)

$6.91 (223.62%)

Buy

18

3 months 13 days ago

2/9 (22.22%)

$12.2 (210.34%)

94

Hold

35

3 months 16 days ago

1/2 (50%)

$19.71 (128.91%)

6

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ALLO (Allogene Therapeutics) average time for price targets to be met?

On average it took 80.79 days on average for the stock forecasts to be realized with a an average price target met ratio 25.8

Which analyst has the current highest performing score on ALLO (Allogene Therapeutics) with a proven track record?

MARK BREIDENBACH

Which analyst has the most public recommendations on ALLO (Allogene Therapeutics)?

Mark Breidenbach has 4 price targets and 2 ratings on ALLO

Which analyst is the currently most bullish on ALLO (Allogene Therapeutics)?

Luca Issi with highest potential upside - $28.02

Which analyst is the currently most reserved on ALLO (Allogene Therapeutics)?

Asthika Goonewardene with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?